What’s Happening With Moderna Stock?

SourceForbes
SectorFinancial Markets
CountryMiddle east

An illustrative photo showing medical syringes seen in front of Moderna logo displayed on screens in ... [+] the background on Christmas Eve. On Thursday, December 24, 2020, in Dublin, Ireland. (Photo illustration by Artur Widak/NurPhoto via Getty Images) NurPhoto via Getty Images Moderna (NASDAQ: MRNA) stock rose by about 4% over the last week to levels of around $113 per share.

Here’s a quick rundown of the developments for the company over the last week. Firstly, Moderna raised the low-end of its global production estimate for its vaccine from 500 million doses to 600 million doses in 2021, and also signed a new agreement for fill-finish operations for its vaccine, with Swedish contract manufacturer Recipharm. The company is looking to produce as many as 1 billion doses of its vaccine for the full year. Secondly, the European Union’s drug regulator approved the Moderna vaccine for use, with the first doses expected to arrive this week. The vaccine was also approved by the U.K, which has ordered about 17 million doses of the shot, which will likely be delivered by Spring. Separately, Moderna’s CEO said that people inoculated with its vaccine were likely to be protected ...read more...